Xabier Agirre Selected Research

Xabier Agirre Research Topics

Disease

33	Neoplasms (Cancer) 01/2023 - 06/2003
10	Multiple Myeloma 01/2023 - 04/2015
7	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 09/2009 - 12/2003
6	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 07/2012 - 06/2003
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 10/2011
4	Hematologic Neoplasms (Hematological Malignancy) 11/2021 - 06/2003
4	B-Cell Lymphoma (Lymphoma, B Cell) 01/2016 - 09/2009
3	Lymphoma (Lymphomas) 01/2017 - 10/2010
3	Blast Crisis (Blast Phase) 03/2008 - 07/2005
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2024 - 01/2019
2	Prostatic Neoplasms (Prostate Cancer) 06/2022 - 12/2010
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2017 - 10/2015
2	Fanconi Anemia (Fanconi's Anemia) 03/2012 - 08/2007
2	Leukemia 10/2010 - 08/2006
2	Carcinogenesis 12/2009 - 05/2009
2	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 10/2005 - 06/2003
1	Rotator Cuff Injuries 04/2024
1	Genetic Translocation (Chromosomal Translocation) 10/2022
1	Melanoma (Melanoma, Malignant) 01/2022
1	Skin Neoplasms (Skin Cancer) 01/2022
1	Hypersensitivity (Allergy) 01/2019
1	Hepatocellular Carcinoma (Hepatoma) 01/2019
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2018
1	Trisomy (Trisomies) 01/2018
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 10/2015
1	Plasma Cell Neoplasms 04/2015
1	Thrombocytopenia (Thrombopenia) 04/2012
1	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 01/2012
1	Neoplasm Metastasis (Metastasis) 01/2012
1	Chromosome Aberrations (Chromosome Abnormalities) 12/2010
1	Lower Urinary Tract Symptoms 12/2010
1	Burkitt Lymphoma (Burkitt's Lymphoma) 10/2010
1	Colorectal Neoplasms (Colorectal Cancer) 12/2009
1	T-Cell Prolymphocytic Leukemia (Leukemia, T Cell, Chronic) 09/2009

Drug/Important Bio-Agent (IBA)

11	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 11/2005
8	MicroRNAs (MicroRNA)IBA 01/2012 - 05/2007
6	MethyltransferasesIBA 06/2022 - 01/2017
5	Histones (Histone)IBA 01/2024 - 10/2011
5	Imatinib Mesylate (Gleevec)FDA Link 09/2009 - 12/2003
4	Histone MethyltransferasesIBA 01/2022 - 10/2015
4	ChromatinIBA 01/2021 - 01/2018
3	Lysine (L-Lysine)FDA Link 01/2021 - 10/2011
3	Biomarkers (Surrogate Marker)IBA 12/2010 - 10/2005
3	AntigensIBA 11/2007 - 06/2003
2	Retroelements (Retrotransposon)IBA 01/2021 - 11/2005
2	Histone Deacetylase InhibitorsIBA 11/2019 - 10/2010
2	Transcription Factors (Transcription Factor)IBA 01/2019 - 08/2011
2	Proteins (Proteins, Gene)FDA Link 01/2016 - 04/2012
2	hydrogen sulfite (bisulfite)IBA 04/2015 - 11/2007
2	Messenger RNA (mRNA)IBA 01/2012 - 07/2005
2	nuclear pore complex protein 98IBA 03/2005 - 06/2003
1	Vorinostat FDA Link 04/2024
1	Lipid NanoparticlesIBA 01/2023
1	Long Noncoding RNAIBA 01/2023
1	Small Interfering RNA (siRNA)IBA 01/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	NucleotidesIBA 10/2022
1	Inositol (Myoinositol)IBA 01/2022
1	CholesterolIBA 01/2022
1	Methotrexate (Mexate)FDA LinkGeneric 01/2022
1	Immunomodulating AgentsIBA 11/2021
1	Antiviral Agents (Antivirals)IBA 01/2021
1	venetoclaxIBA 01/2021
1	Adenosine Triphosphate (ATP)IBA 01/2021
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2021
1	Proto-Oncogene Proteins c-bcl-2 (Proto Oncogene Proteins c bcl 2)IBA 01/2021
1	CaspasesIBA 01/2021
1	Nerve Growth Factor (NGF)IBA 11/2020
1	A-Form DNA (A-DNA)IBA 11/2020
1	Proteasome InhibitorsIBA 01/2020
1	IntegrinsIBA 01/2020
1	Bortezomib (Velcade)FDA Link 01/2020
1	Enhancer RNAsIBA 01/2019
1	Programmed Cell Death 1 ReceptorIBA 01/2019
1	Deoxyribonucleases (DNase)FDA Link 01/2019
1	Immune Checkpoint InhibitorsIBA 01/2019
1	4-aminoquinolineIBA 08/2018
1	EnzymesIBA 08/2018
1	polycationsIBA 10/2017
1	PolyaminesIBA 10/2017
1	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 01/2017
1	InterferonsIBA 01/2017
1	Histone-Lysine N-MethyltransferaseIBA 10/2015
1	Tyrosine Kinase InhibitorsIBA 07/2012
1	human MIrn181 microRNAIBA 03/2012
1	5-Methylcytosine (5 Methylcytosine)IBA 01/2012
1	5-hydroxymethylcytosineIBA 01/2012
1	histone H3 trimethyl Lys4IBA 01/2011
1	Immunoglobulin M (IgM)IBA 10/2010
1	human MIRN137 microRNAIBA 12/2009
1	N 30IBA 09/2009
1	human MIRN124 microRNAIBA 05/2009
1	Therapeutic UsesIBA 08/2007

Therapy/Procedure

17	Therapeutics 01/2023 - 07/2005
6	Immunotherapy 01/2023 - 02/2007
2	Precision Medicine 06/2022 - 01/2022
2	Aftercare (After-Treatment) 10/2010 - 07/2005
1	Castration 06/2022
1	Salvage Therapy 10/2010
1	Drug Therapy (Chemotherapy) 10/2010